Latest blog articles

How do we guarantee access to COVID-19 vaccines and therapies, and secure health-related human rights for all? We’ve heard a string of promises in the race for new vaccines and therapies.

It’s been almost a month since the COVID-19 pandemic has drastically changed the way we live and work. Now that we are more used to, in a manner of speaking, the extraordinary measures to curtail the rampant spread of the virus, it’s time to seriously consider, and openly discuss, this crisis’...

This week I am having the pleasure of attending the 2019 BIO International Convention hosted in Philadelphia, Pennsylvania. The biggest global event of its kind, this international convention brings together stakeholders from across the biotechnologies. Whether it be from the health, agricultural or...

With the painful experiences of new Member States breaching the rule of law and democracy principles inside the EU and no tailor-made remedy to punish and enforce EU values, the Commission suggests in its Western Balkans strategy that future accession treaties could provide for such a mechanism to...

Globally the majority of health-related R&D is invested in medicines with substantial guaranteed returns, yet what is missing is extensive R&D targeted at diseases overwhelmingly prevalent in developing countries. This threatens long-term availability of medicines and treatment options for these...

The UK accepted the EU withdrawal negotiating position almost completely - with one exception - the UK does not have to pay for the moving vans of the EU agencies currently hosted in the UK.